Find the latest pharmaceutical market place for APIs enquiry about Miglustat on PharmaCompass.com.

india-flag Flag

Miglustat API needed in India [ENA20202]

A company that focuses on the development of comprehensive solutions in oral and parenteral drug delivery systems, analytical sciences, and pre-formulation studies is looking for suppliers of Miglustat API for both development & commercial purposes. The suppliers must support this enquiry with USDMF & CoA.

Reply

07 Aug 2024

india-flag Flag

USP Grade Nystatin (2.6 kg) API needed in India [ENA17551]

A company that deals in trading of various pharmaceutical products is looking for suppliers of USP Grade Nystatin (2.6 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.

Reply

13 Jul 2023

india-flag Flag

Miglustat (MOQ) API needed in India [ENA06979]

A pharmaceutical manufacturing and R&D company that deals in a wide range of products in various therapeutic segments like Pain, CNS, Cardiovascular, Diabetes & gastroenterology is looking for suppliers of Miglustat (MOQ) API for formulation development. The suppliers must support thsi enquiry with EU/USDMF & CoA.

Reply

31 Mar 2020

Miglustat, Sapropterin and other APIs needed in Iran [ENA05309]

A privately owned, knowledge-driven company active in developing, manufacturing and marketing chemical and biological pharmaceutical products is looking for suppliers of APIs mentioned below.
1. Miglustat
2. Sapropterin
3. Pirfenidone.

Reply

30 Sep 2019

USP/EP grade Miglustat and Lifitegrast APIs needed in Iran [ENA04551]

A generic developing company mainly dealing in injectables, solid dosage forms and sterile drops is looking for suppliers of USP/EP grade Miglustat and Lifitegrast APIs.

Reply

04 Jul 2019

Enquiry// Miglustat API needed in New Zealand [ENA00656]

A New Zealand based pharma product development organisation providing global pharma R&D solutions is looking for suppliers of Miglustat API for domestic consumption. The current requirement is for 70 kg for development and 42 kg as pre-exhibit quantity.

Reply

12 Jan 2018

Enquiry//Development quantities of Miglustat needed for Iran [EN00239]

A manufacturing company in Iran is looking for R&D quantities of Miglustat API for generic drug development. With almost USD 100 million in annual sales, Miglustat is the API for Actelion’s product Zavesca. https://www.pharmacompass.com/active-pharmaceutical-ingredients/miglustat

Reply

21 Jan 2016